tallózása szerző szerint "Sumerauer D"

A találatok rendezése: Rendezés: Találatok:

  • Cribriform neuroepithelial tumor: Molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome. 
    Johann PD; Hovestadt V; Thomas C; Jeibmann A; Hess K; Bens S; Oyen F; Hawkins C; Pierson CR; Aldape K; Kim SP; Widing E; Sumerauer D; Hauser, Péter; van Landeghem F; Ryzhova M; Korshunov A; Capper D; Jones DT; Pfister SM; Schneppenheim R; Siebert R; Paulus W; Fruhwald MC; Kool M; Hasselblatt M (2017)
    Rhabdoid phenotype and loss of SMARCB1 expression in a brain tumor are characteristic features of atypical teratoid/rhabdoid tumors (ATRT). Rare non-rhabdoid brain tumors showing cribriform growth pattern and SMARCB1 loss ...
  • Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease 
    van Zanten SE; Baugh J; Chaney B; De Jongh D; Aliaga ES; Barkhof F; Noltes J; De Wolf R; Van Dijk J; Cannarozzo A; Damen-Korbijn CM; Lieverst JA; Colditz N; Hoffmann M; Warmuth-Metz M; Bison B; Jones DT; Sturm D; Gielen GH; Jones C; Hulleman E; Calmon R; Castel D; Varlet P; Giraud G; Slavc I; Van Gool S; Jacobs S; Jadrijevic-Cvrlje F; Sumerauer D; Nysom K; Pentikainen V; Kivivuori SM; Leblond P; Entz-Werle N; von Bueren AO; Kattamis A; Hargrave DR; Hauser P; Garami, Miklós; Thorarinsdottir HK; Pears J; Gandola L; Rutkauskiene G; Janssens GO; Torsvik IK; Perek-Polnik M; Gil-da-Costa MJ; Zheludkova O; Shats L; Deak L; Kitanovski L; Cruz O; La Madrid AM; Holm S; Gerber N; Kebudi R; Grundy R; Lopez-Aguilar E; Zapata-Tarres M; Emmerik J; Hayden T; Bailey S; Biassoni V; Massimino M; Grill J; Vandertop WP; Kaspers GJ; Fouladi M; Kramm CM; van Vuurden DG; members of the SIOPE DIPG Network (2017)
    Diffuse intrinsic pontine glioma (DIPG) is a rare and deadly childhood malignancy. After 40 years of mostly single-center, often non-randomized trials with variable patient inclusions, there has been no improvement in ...
  • Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma 
    Northcott PA; Lee C; Zichner T; Stutz AM; Erkek S; Kawauchi D; Shih DJ; Hovestadt V; Zapatka M; Sturm D; Jones DT; Kool M; Remke M; Cavalli FM; Zuyderduyn S; Bader GD; VandenBerg S; Esparza LA; Ryzhova M; Wang W; Wittmann A; Stark S; Sieber L; Seker-Cin H; Linke L; Kratochwil F; Jager N; Buchhalter I; Imbusch CD; Zipprich G; Raeder B; Schmidt S; Diessl N; Wolf S; Wiemann S; Brors B; Lawerenz C; Eils J; Warnatz HJ; Risch T; Yaspo ML; Weber UD; Bartholomae CC; von Kalle C; Turányi, Eszter; Hauser, Péter; Sanden E; Darabi A; Siesjo P; Sterba J; Zitterbart K; Sumerauer D; van Sluis P; Versteeg R; Volckmann R; Koster J; Schuhmann MU; Ebinger M; Grimes HL; Robinson GW; Gajjar A; Mynarek M; von Hoff K; Rutkowski S; Pietsch T; Scheurlen W; Felsberg J; Reifenberger G; Kulozik AE; von Deimling A; Witt O; Eils R; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Korbel JO; Wechsler-Reya RJ; Pfister SM (2014)
    Medulloblastoma is a highly malignant paediatric brain tumour currently treated with a combination of surgery, radiation and chemotherapy, posing a considerable burden of toxicity to the developing child. Genomics has ...
  • Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis 
    Hasselblatt M; Thomas C; Hovestadt V; Schrimpf D; Johann P; Johann P; Bens S; Oyen F; Peetz-Dienhart S; Crede Y; Wefers A; Vogel H; Riemenschneider MJ; Antonelli M; Giangaspero F; Bernardo MC; Giannini C; Ud Din N; Perry A; Keyvani K; van Landeghem F; Sumerauer D; Hauser, Péter; Capper D; Korshunov A; Jones DT; Pfister SM; Schneppenheim R; Siebert R; Fruhwald MC; Kool M (2016)
  • Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas 
    Lassaletta A; Zapotocky M; Mistry M; Ramaswamy V; Honnorat M; Krishnatry R; Stucklin AG; Zhukova N; Arnoldo A; Ryall S; Ling C; McKeown, T; Loukides J; Cruz O; de Torres C; Ho CY; Packer RJ; Tatevossian R; Qaddoumi I; Harreld JH; Dalton JD; Mulcahy-Levy J; Foreman N; Karajannis MA; Wang SY; Snuderl M; Rao AN; Giannini C; Kieran M; Ligon KL; Garre ML; Nozza P; Mascelli S; Raso A; Mueller S; Nicolaides T; Silva K; Perbet R; Vasiljevic A; Conter CF; Frappaz D; Leary S; Crane C; Chan A; Ng HK; Shi ZF; Mao Y; Finch E; Eisenstat D; Wilson B; Carret AS; Hauser, Péter; Sumerauer D; Krskova L; Larouche V; Fleming A; Zelcer S; Jabado N; Rutka JT; Dirks P; Taylor MD; Chen SY; Bartels U; Huang A; Ellison DW; Bouffet E; Hawkins C; Tabori U (2017)
    Purpose BRAF V600E is a potentially highly targetable mutation detected in a subset of pediatric low-grade gliomas (PLGGs). Its biologic and clinical effect within this diverse group of tumors remains unknown. Patients and ...